TCI Wealth Advisors, Inc. - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 36 filers reported holding OCUPHIRE PHARMA INC in Q4 2022. The put-call ratio across all filers is 3.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q1 2023$8
+14.3%
20.0%0.00%
Q4 2022$720.0%0.00%
Q3 2022$020.0%0.00%
Q2 2022$020.0%0.00%
Q1 2022$020.0%0.00%
Q4 2021$020.0%0.00%
Q3 2021$020.0%0.00%
Q2 2021$020.0%0.00%
Q1 2021$020.0%0.00%
Q4 2020$020.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 328,970$1,161,2641.63%
RICE HALL JAMES & ASSOCIATES, LLC 806,067$2,845,4170.16%
Diametric Capital, LP 23,598$83,3010.04%
MAI Capital Management 440,071$1,553,4510.03%
Bedel Financial Consulting, Inc. 15,000$52,9500.01%
Legato Capital Management LLC 16,456$58,0900.01%
Stokes Family Office, LLC 12,120$42,7840.01%
CarsonAllaria Wealth Management, Ltd. 1,000$40.00%
Tower Research Capital LLC (TRC) 5,103$180.00%
Renaissance Technologies 189,500$6690.00%
View complete list of OCUPHIRE PHARMA INC shareholders